Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schnyder

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Analytical Biochemistry|January 1, 1992
Spectrophotometric method to quantify and discriminate urokinase and tissue-type plasminogen activatorsJ Schnyder, R Marti, P H Cooper, et al.
Immunobiology|April 1, 1982
Phagocytosis-stimulated macrophages. Production of prostaglandins and SRS-A, and prostaglandin effects on macrophage activationM Baggiolini, J Schnyder, B Dewald, et al.
Zeitschrift Fur Rheumatologie|May 1, 1989
[Initial clinical experiences in the treatment of chronic polyarthritis with a new monokine release inhibitor]M J Seibel, W Brückle, M Respondek, et al.
Experimental Cell Research|April 1, 1987
Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analoguesM Baggiolini, B Dewald, J Schnyder, et al.
Cytokine|October 1, 1996
Induction of rapid IL-1 beta mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3'UTR by a radicicol analogueT Kastelic, J Schnyder, A Leutwiler, et al.
Arthritis and Rheumatism|December 1, 1987
Effect of synthetic calcium pyrophosphate and hydroxyapatite crystals on the interaction of human blood mononuclear cells with chondrocytes, synovial cells, and fibroblastsJ M Dayer, V Evêquoz, C Zavadil-Grob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinasesR Vallon, F Freuler, N Desta-Tsedu, et al.
British Journal of Cancer|February 16, 2012
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerA A Chiappori, M T Schreeder, M M Moezi, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Analytical Biochemistry|January 1, 1992
Spectrophotometric method to quantify and discriminate urokinase and tissue-type plasminogen activatorsJ Schnyder, R Marti, P H Cooper, et al.
Immunobiology|April 1, 1982
Phagocytosis-stimulated macrophages. Production of prostaglandins and SRS-A, and prostaglandin effects on macrophage activationM Baggiolini, J Schnyder, B Dewald, et al.
Zeitschrift Fur Rheumatologie|May 1, 1989
[Initial clinical experiences in the treatment of chronic polyarthritis with a new monokine release inhibitor]M J Seibel, W Brückle, M Respondek, et al.
Experimental Cell Research|April 1, 1987
Inhibition of the phagocytosis-induced respiratory burst by the fungal metabolite wortmannin and some analoguesM Baggiolini, B Dewald, J Schnyder, et al.
Cytokine|October 1, 1996
Induction of rapid IL-1 beta mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3'UTR by a radicicol analogueT Kastelic, J Schnyder, A Leutwiler, et al.
Arthritis and Rheumatism|December 1, 1987
Effect of synthetic calcium pyrophosphate and hydroxyapatite crystals on the interaction of human blood mononuclear cells with chondrocytes, synovial cells, and fibroblastsJ M Dayer, V Evêquoz, C Zavadil-Grob, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinasesR Vallon, F Freuler, N Desta-Tsedu, et al.
British Journal of Cancer|February 16, 2012
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancerA A Chiappori, M T Schreeder, M M Moezi, et al.
Pageof 3